As mentioned earlier, there is an urgent need for the development of novel antibiotics targeting S. aureus. Fortunately, a number of new agents active against MRSA and other Gram-positive ...

Resistance development of MRSA has become a global health problem. New resistance types, such as vancomycin-resistant S. aureus, have been recently developed. Novel antibiotics, such as linezolid ...

IT has been noticed that certain antibiotics, when tested against Staphylococcus aureus (H strain, N.C.T.C. Nor 6571) by the cylinder-plate method1, give zones f inhibition which have clear edges ...

it will be the first antibiotic in the beta-lactam class to or the treatment of SAB S. aureus, including hard-to-treat infections caused by methicillin-resistant strains (MRSA), said Basilea.

Innoviva (INVA) announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica for the commercialization of Zevtera, an advanced-generation cephalosporin ...

As with penicillin, only a year passed after this semi-synthetic penicillin was released before methicillin-resistant Staph aureus (MRSA) was reported. Initially, MRSA only appeared in hospitals ...